Last Updated 1 March 2021.
1 Vaccine Approved for Use in Japan
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
8 Vaccines in Clinical Trials in Japan
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 other countries
6 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 58 other countries
22 trials in 13 countries
-
Takeda
TAK-019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-919- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country